Søby, Sebastian, et al. “Pembrolizumab As First-Line Treatment for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Multi-Institutional DAHANCA Cohort Study”. Acta Oncologica, vol. 64, Sept. 2025, pp. 1269-75, doi:10.2340/1651-226X.2025.44327.